ECG Fundamentals

Lead Placement — Limb Leads
Lead ILA (+) vs RA (-) — lateral view
Lead IILL (+) vs RA (-) — inferior view; best for P waves
Lead IIILL (+) vs LA (-) — inferior view
aVRRA augmented — global ischaemia, LMCA occlusion
aVLLA augmented — high lateral view
aVFLL augmented — inferior view
⚠ Misplacement Warning

Lead reversal (especially LA/RA swap) produces inverted P in I and aVR positive — mimics dextrocardia. Always verify placement before clinical decisions.

Lead Placement — Precordial Leads
V14th ICS, right sternal border
V24th ICS, left sternal border
V3Between V2 and V4
V45th ICS, mid-clavicular line
V5Anterior axillary line (same level as V4)
V6Mid-axillary line (same level as V4-V5)
ℹ Female Patients

Place precordial leads under breast tissue, not on top — breast tissue displacement is a leading cause of T-wave abnormalities in women.

ECG Paper & Measurement Standards
Paper Speed
Standard25 mm/s
Small square1 mm = 0.04 sec
Large square5 mm = 0.20 sec
Amplitude
Standard gain10 mm/mV
Half standard5 mm/mV (LVH)
Double20 mm/mV (small voltages)
Heart Rate
Regular rhythm300 ÷ R-R (large sq.)
IrregularCount QRS in 10 sec × 6
Quick estimate300-150-100-75-60-50
ECG Waveform Components
ComponentRepresentsNormal Duration / ValueKey Leads
P WaveAtrial depolarisation0.08 – 0.12 s; < 2.5 mm tallBest in II and V1
PR IntervalAV nodal conduction0.12 – 0.20 sMeasure in II
QRS ComplexVentricular depolarisationNarrow < 0.12 s; Wide ≥ 0.12 sAll leads
ST SegmentEarly ventricular repolarisationIsoelectric (at baseline)Contiguous leads for STEMI
T WaveVentricular repolarisationUpright in I, II, V3-V6; inverted aVRAll leads
QT IntervalTotal ventricular repolarisationQTc < 440 ms (M), < 460 ms (F)II or V5
U WavePurkinje/papillary repolarisationSmall deflection after T waveV2-V3; prominent in hypokalaemia
QTc Bazett Formula
QTc = QT ÷ √RR
RR interval in seconds. QT measured from start of QRS to end of T wave.
Normal — Male< 440 ms
Normal — Female< 460 ms
Borderline440–500 ms — review drugs
Prolonged> 500 ms — high TdP risk
⚠ Torsades de Pointes Risk

QTc > 500 ms = significant risk of Torsades de Pointes (polymorphic VT). Discontinue causative drugs, correct electrolytes (K⁺ ≥ 4.0, Mg²⁺ ≥ 0.8).

Systematic ECG Reading — 10-Step Approach
  1. Rate: Calculate using 300 ÷ R-R (large squares). Normal 60-100 bpm.
  2. Rhythm: Regular or irregular? Mark R-R intervals with calipers. Regularly irregular vs. irregularly irregular.
  3. P Wave: Present? Morphology consistent? One P per QRS? Upright in II, inverted in aVR?
  4. PR Interval: Measure in lead II. Normal 0.12–0.20 s. Prolonged = heart block. Short = pre-excitation.
  5. QRS Width: Narrow (< 0.12 s) = supraventricular origin. Wide (≥ 0.12 s) = BBB, aberrancy, or ventricular.
  6. ST Segment: Elevation (≥ 1 mm limb, ≥ 2 mm precordial) or depression? Morphology: concave/convex/saddle?
  7. T Wave: Upright or inverted? Peaked (hyperkalaemia) or flat/biphasic (ischaemia, Wellens').
  8. QT Interval: Measure QT, calculate QTc. Review drugs if prolonged.
  9. Axis: Normal −30° to +90°. Check leads I and aVF for quick assessment.
  10. Overall Interpretation: Correlate with clinical context, vitals, and symptoms. Never interpret ECG in isolation.

Normal vs Abnormal ECG Patterns

Normal Sinus Rhythm Criteria
  • P wave before every QRS complex
  • QRS complex after every P wave
  • Consistent PR interval (0.12–0.20 s)
  • P wave upright in II, inverted in aVR
  • Heart rate 60–100 bpm
  • Regular R-R intervals (< 10% variation)
Cardiac Axis
Normal axis−30° to +90°
LAD (< −30°)LBBB, LVH, inferior MI, LAFB
RAD (> +90°)RVH, RBBB, PE, lateral MI, LPFB
Extreme RAD> +180° — lead reversal?
Quick method: Lead I (+) and aVF (+) = normal axis. Lead I (+) aVF (−) = LAD. Lead I (−) aVF (+) = RAD.
Ventricular Hypertrophy Criteria
Left Ventricular Hypertrophy (LVH)
Sokolow-LyonS(V1) + R(V5 or V6) > 35 mm
Cornell voltageR(aVL) + S(V3) > 28 mm (M), > 20 mm (F)
AssociatedStrain pattern: ST depression + T inversion lateral leads
Right Ventricular Hypertrophy (RVH)
Dominant R in V1R:S ratio > 1 in V1
Right axis deviation> +90°
Deep S in V5-V6Tall R V1 + deep S V5/V6
CausesPulmonary hypertension, PE, ASD, PS
Bundle Branch Blocks
WiLLiaM
LBBB pattern:
W shape in V1 (QS or rS)
M shape in V5/V6 (notched R)
QRS > 0.12 s | No normal septal Q in I, V6
New LBBB + Chest Pain

Treat as STEMI equivalent. Apply Sgarbossa criteria if LBBB known old.

MaRRoW
RBBB pattern:
M shape (RSR') in V1
W shape (wide S) in V5/V6
QRS > 0.12 s | Causes: PE, ASD, ischaemia
Incomplete RBBB

RSR' in V1 with QRS < 0.12 s. Normal variant, but new RBBB warrants investigation (PE, ASD).

Ischaemia, Injury & Infarction — The Progression
Ischaemia
  • T-wave changes (inversion or hyperacute)
  • ST depression (subendocardial)
  • Reversible with reperfusion
Injury (STEMI)
  • ST elevation in ≥ 2 contiguous leads
  • Convex (tombstone) morphology
  • Reciprocal ST depression in opposite leads
Infarction (Q waves)
  • Pathological Q wave: > 0.04 s AND > 25% of R height
  • Indicates transmural necrosis
  • Permanent (scar)
STEMI Territories
Anterior STEMI
Leads V1–V4 | Artery: LAD | Risk: cardiogenic shock, heart failure, VT/VF
Inferior STEMI
Leads II, III, aVF | Artery: RCA (80%), LCx (20%) | Check right-sided leads for RV infarct (avoid nitrates)
Lateral STEMI
Leads I, aVL, V5–V6 | Artery: LCx | Often extends from anterior or inferior territory
Posterior STEMI
Dominant R in V1, ST depression V1–V3 (= reciprocal ST elevation posteriorly). Confirm with V7–V9. Artery: LCx or RCA
Wellens' Syndrome
⚠ Critical LAD Stenosis — Do NOT Exercise Test

Wellens' syndrome indicates critical proximal LAD stenosis in a pain-free patient. ECG changes occur between angina episodes.

Type A (25%)Biphasic T waves in V2–V3
Type B (75%)Deeply symmetric inverted T waves V2–V3
TroponinMinimally elevated or normal
ActionUrgent cath lab referral — do NOT discharge

Tachyarrhythmias

Narrow Complex Tachycardias (SVT Overview)
RhythmRateP WaveRegularityKey Feature
Sinus tachycardia100–150Visible before QRS, upright IIRegularPhysiological cause (pain, fever, hypovolaemia)
AVNRT150–250Buried in or just after QRS (pseudo S/R')RegularMost common paroxysmal SVT; responds to vagal/adenosine
AVRT (WPW)150–250Retrograde P after QRSRegularDelta wave during sinus rhythm; AVOID AV nodal blockers in AF+WPW
Atrial flutterAtrial 300Sawtooth pattern (F waves)Regular (2:1, 3:1, 4:1)Ventricular rate 150 at 2:1 block — classic presentation
Atrial fibrillationVaries 100–180No P waves; fibrillatory baselineIrregularly irregularNo two R-R intervals are equal; most common sustained arrhythmia
Atrial Fibrillation — Management Summary
Rate Control
  • Beta-blockers: metoprolol, bisoprolol, atenolol
  • Non-DHP calcium channel blockers: diltiazem, verapamil
  • Digoxin: for AF + heart failure (rate at rest)
  • Target resting rate < 110 bpm (lenient) or < 80 bpm (strict)
Rhythm Control
  • Electrical cardioversion (DC): synchronised shock
  • Flecainide: "pill in pocket" (no structural disease)
  • Amiodarone: AF with LV dysfunction or structural disease
  • Anticoagulate ≥ 3 weeks before if AF > 48 hours (unless TOE-guided)
CHA₂DS₂-VASc Anticoagulation Threshold

Score ≥ 2 (male) or ≥ 3 (female) = anticoagulate. Preferred: DOAC (rivaroxaban, apixaban, dabigatran) over warfarin. C=CHF, H=HTN, A₂=Age≥75(×2), D=DM, S₂=Stroke/TIA(×2), V=Vascular, A=Age65-74, Sc=Sex category(female).

Wide Complex Tachycardias
⚠ Haemodynamic Instability = Immediate Synchronised DC Cardioversion

If VT with pulse + hypotension/altered consciousness/pulmonary oedema — do not delay cardioversion for rhythm confirmation.

Monomorphic VT — Red Flags
  • AV dissociation (P waves independent of QRS)
  • Fusion beats (QRS = part normal + part ventricular)
  • Capture beats (narrow QRS among wide complexes)
  • Concordance (all precordial leads positive or negative)
  • QRS width > 0.14 s in RBBB morphology
  • Brugada criteria: if in doubt — treat as VT
SVT with Aberrancy — Features
  • Typical BBB morphology (RBBB or LBBB pattern)
  • P waves visible before QRS
  • History of pre-existing BBB on previous ECG
  • Response to adenosine (terminates or reveals underlying rhythm)
  • Rate-related aberrancy at fast rates
Polymorphic VT / Torsades de Pointes (TdP)
PatternQRS complexes rotating around baseline
Rate200–250 bpm
TriggerR-on-T phenomenon on prolonged QT
CausesDrugs (QT prolonging), hypokalaemia, hypomagnesaemia, congenital LQTS
Treatment
  • IV Magnesium sulphate 2g over 5–15 min (first-line)
  • Correct potassium ≥ 4.5 mmol/L
  • Stop all QT-prolonging drugs immediately
  • Overdrive pacing if recurrent (keep rate 90–110 bpm)
  • If degenerated to VF: immediate defibrillation
Ventricular Fibrillation (VF)
⚠ Cardiac Arrest — Start CPR Immediately

VF produces no organised QRS, no pulse. Chaotic baseline. Immediate CPR + defibrillation (200J biphasic). Every minute without defibrillation reduces survival by 10%. Follow ACLS/ALS protocol: CPR → shock → CPR 2 min → adrenaline → amiodarone.

Bradyarrhythmias & Conduction Disorders

Sinus Bradycardia
DefinitionRate < 60 bpm with normal P-QRS morphology
PhysiologicalAthletes, sleep, vagal stimulation
PathologicalBeta-blockers, hypothyroidism, inferior MI, sick sinus syndrome, raised ICP
AsymptomaticMonitor, investigate cause
SymptomaticAtropine 0.5–1 mg IV (up to 3 mg total)
RefractoryTranscutaneous/transvenous pacing
AV Heart Blocks — Classification
Block TypeECG FeatureRisk LevelManagement
1st Degree PR > 0.20 s; all P waves conducted Benign Monitor only; no treatment required
2nd Degree Mobitz I (Wenckebach) Progressive PR lengthening → dropped QRS; QRS normal Low-Moderate Usually benign; monitor. Consider pacing if symptomatic. Common in inferior MI.
2nd Degree Mobitz II Fixed PR interval + sudden dropped QRS; often wide QRS HIGH RISK Permanent pacemaker indicated. Can progress to complete block without warning.
2:1 AV Block Alternate P waves conducted; cannot classify as Mobitz I or II without longer strip Requires Assessment Obtain longer rhythm strip; treat as Mobitz II until proven otherwise if wide QRS.
3rd Degree (Complete) Complete AV dissociation; independent P and QRS; both regular but unrelated EMERGENCY Urgent pacemaker if symptomatic. Atropine (may not help — often nodal/infranodal). Transcutaneous pacing as bridge.
⚠ 3rd Degree Heart Block — Nursing Actions

Place patient supine, O₂, IV access, continuous monitoring, 12-lead ECG. Alert cardiology immediately. Prepare atropine, transcutaneous pacer pads. Do NOT leave patient unattended.

Escape Rhythms
Junctional Escape
Rate40–60 bpm
QRSNarrow (AV node–His)
P wavesAbsent, inverted, or retrograde after QRS
StabilityRelatively stable; can support life
Ventricular Escape (Idioventricular)
Rate20–40 bpm
QRSWide (> 0.12 s), bizarre morphology
P wavesIndependent (AV dissociation)
StabilityVery unstable — do NOT suppress with lidocaine
⚠ Do NOT Suppress Escape Rhythms

Ventricular escape is a life-saving mechanism. Administering lidocaine or other antiarrhythmics will cause asystole. Treat the underlying cause and pace.

Sick Sinus Syndrome
  • Sinus bradycardia + tachyarrhythmia alternating (tachy-brady syndrome)
  • Sinus pauses or arrest (> 3 seconds = significant)
  • Sinoatrial exit block
  • Most common in elderly; causes: fibrosis, ischaemia, cardiac surgery
  • Treatment: permanent pacemaker + anticoagulation for AF component
Wolff-Parkinson-White (WPW) Syndrome
Delta waveSlurred upstroke at start of QRS
Short PR< 0.12 s (accessory pathway bypasses AV delay)
Wide QRSPre-excitation widens QRS
MechanismBundle of Kent — accessory pathway
⚠ WPW + AF = Dangerous

AF can conduct rapidly via accessory pathway (ventricular rates 200–300 bpm) → VF. AVOID AV nodal blockers (adenosine, beta-blockers, digoxin, diltiazem). Use procainamide or DC cardioversion. Refer for ablation.

Cardiac Monitoring & Nursing Practice

Continuous Cardiac Monitoring — Lead Selection
LeadBest ForWhy
Lead IIGeneral rhythm monitoring; P wave assessmentParallel to electrical axis — best P wave visibility and tallest QRS
V1 / MCL1P wave morphology; bundle branch block differentiationBest for seeing retrograde P, distinguishing RBBB vs LBBB, VT vs SVT
Lead III or aVFInferior wall monitoring (post-inferior MI)Inferior territory surveillance for re-occlusion
Combined II + V1Dual-lead telemetry (optimal)Maximises arrhythmia and conduction detection sensitivity
12-Lead ECG Technique — Nursing Standards
Skin Preparation
  1. Explain procedure and obtain consent
  2. Expose chest — maintain dignity with sheet
  3. Clip excessive chest hair if needed (explain rationale)
  4. Lightly abrade skin with gauze to remove dead cells
  5. Clean with alcohol swab, allow to dry completely
  6. Apply electrodes to clean, dry, non-hairy sites
Artefact Recognition
Muscle tremorIrregular baseline noise — patient warm and relaxed, support limbs
Baseline wanderSlow wave undulation — check electrode contact, patient breathing
AC interferenceRegular 50/60 Hz noise — disconnect nearby electrical equipment
Loose leadFlat line or intermittent signal in one lead only — reattach electrode
STEMI Pathway & Nursing Role
⚠ Door-to-Balloon (DTB) Time Target: < 90 Minutes

Every minute of delay = more myocardium lost. The nursing team's speed in recognition and activation is critical to patient outcomes.

  1. Recognition: Patient with chest pain → 12-lead ECG within 10 minutes of arrival
  2. Interpretation: ST elevation ≥ 1 mm in ≥ 2 contiguous limb leads or ≥ 2 mm in ≥ 2 contiguous precordial leads
  3. STEMI Alert Activation: Call cardiologist/cath lab team immediately. Do not wait for troponin results.
  4. Dual Antiplatelet Therapy: Aspirin 300 mg + Ticagrelor 180 mg (or Prasugrel 60 mg if PCI). Crushed/chewed for rapid absorption.
  5. Anticoagulation: Heparin/LMWH per protocol. Fondaparinux for NSTEMI.
  6. IV Access: Large-bore IV ×2, bloods (troponin, FBC, U&E, coagulation, group & save)
  7. Monitoring: Continuous ECG monitoring, SpO₂, BP q15min, defibrillator nearby
  8. Transfer: Accompany patient to cath lab — do not delay for non-essential interventions
  9. Thrombolysis alternative: If PCI not available within 120 minutes, administer thrombolysis (tenecteplase weight-based)
  10. Documentation: Record time of symptom onset, first medical contact, ECG time, activation time, and DTB time
Post-PCI Nursing Care
Radial Access (Preferred)
  • TR Band (inflatable haemostatic device) in situ
  • Assess hand for colour, warmth, capillary refill, radial pulse
  • Monitor for haematoma under band
  • Begin band deflation protocol per unit policy (typically 1–2 hours)
  • Patent haemostasis technique — keep radial patent
Femoral Access
  • Manual compression or vascular closure device (Angioseal, Perclose)
  • Observe for haematoma, retroperitoneal bleed (back/flank pain)
  • Bed rest 2–4 hours post-sheath removal
  • Monitor pedal pulses, CRT, warmth distal to puncture site
  • Neurological obs: numbness/weakness (femoral nerve compression)
Post-PCI Drug Regime (DAPT)
Aspirin75–100 mg daily indefinitely
Ticagrelor90 mg BD for 12 months (ACS). Dyspnoea side effect — not bronchospasm.
Prasugrel10 mg daily (avoid if age >75, weight <60 kg, history of stroke/TIA)
ACE inhibitorStart within 24h — reduces remodelling
High-dose statinAtorvastatin 80 mg — plaque stabilisation
Troponin Interpretation in ACS
High-sensitivity cTnI/cTnTDetectable within 1–2 hours of symptom onset
Rise and fall patternRequired for diagnosis — single elevated value is not sufficient alone
0h/1h algorithmESC rapid rule-out: baseline + 1-hour sample (or 0h/2h/3h)
STEMI exceptionDo NOT wait for troponin — ECG diagnosis is sufficient for STEMI activation
Non-cardiac causesPE, myocarditis, sepsis, renal failure, stroke can elevate troponin (type 2 MI)

GCC Clinical Context & Exam Preparation

GCC-Specific Clinical Considerations
  • STEMI DTB time: KPI across all GCC cardiac centres (MOH, SEHA, HMC, KFSH) — < 90 min target. National cardiac registries track compliance.
  • AF prevalence: Rising sharply with ageing population, T2DM epidemic, and HTN burden across Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman.
  • Congenital long QT: Consanguineous family structures increase prevalence of inherited channelopathies (LQTS1, LQTS2, LQTS3) — family history critical.
  • Brugada syndrome: Underdiagnosed in GCC — provoked by fever (common in summer). Sodium channel blocker challenge (ajmaline/flecainide) in EP lab.
  • Ramadan fasting: Medication timing adjustments critical — QT-prolonging drugs, antiarrhythmics, anticoagulants. Consult cardiology before Ramadan.
QT-Prolonging Drugs Common in GCC Practice
⚠ Check EVERY Prescription for QT Risk

Multiple QT-prolonging drugs = additive risk. Use CredibleMeds (Arizona CERT) database to check drug interactions.

AntibioticsAzithromycin, clarithromycin, moxifloxacin, ciprofloxacin
AntimalarialsChloroquine, hydroxychloroquine
AntipsychoticsHaloperidol, quetiapine, ziprasidone
AntiemeticsDomperidone, ondansetron (high dose IV), metoclopramide
AntiarrhythmicsAmiodarone, sotalol, quinidine, procainamide
AntifungalsFluconazole, voriconazole
DHA / DOH / SCFHS High-Yield ECG Topics for Licensing Exams
  • STEMI territory identification from leads affected
  • Differentiating Mobitz I vs Mobitz II AV block
  • WPW features and contraindicated drugs
  • VT vs SVT with aberrancy differentiation
  • QTc calculation and TdP risk
  • Complete heart block ECG features and management
  • Atrial flutter with 2:1 block (ventricular rate 150)
  • LBBB as STEMI equivalent (Sgarbossa)
  • Posterior STEMI (reciprocal changes V1-V3)
  • Wellens' syndrome — do NOT exercise or discharge
10 Practice MCQs — ECG & Arrhythmia
Q1. A patient presents with a regular narrow complex tachycardia at 150 bpm. The ECG shows sawtooth-pattern flutter waves. What is the most likely ventricular-to-atrial conduction ratio?
  • 1:1
  • 2:1
  • 4:1
  • 3:2
Answer: B — 2:1
Atrial flutter typically has an atrial rate of 300 bpm. With 2:1 AV block, the ventricular rate is 150 bpm, which is the classic presentation. Always consider flutter when ventricular rate is exactly 150 bpm.
Q2. A patient's ECG shows progressive PR interval lengthening followed by a dropped QRS complex. This pattern then repeats. Which AV block is described?
  • First-degree AV block
  • Second-degree Mobitz I (Wenckebach)
  • Second-degree Mobitz II
  • Third-degree (complete) AV block
Answer: B — Second-degree Mobitz I (Wenckebach)
Wenckebach is characterised by progressive PR lengthening until a QRS is dropped, then the cycle resets. It is generally benign and often associated with inferior MI or increased vagal tone.
Q3. A patient with chest pain has an ECG showing ST elevation in II, III, and aVF. Which coronary artery is most likely occluded?
  • Left anterior descending (LAD)
  • Left main coronary artery (LMCA)
  • Right coronary artery (RCA)
  • Left circumflex artery (LCx)
Answer: C — Right coronary artery (RCA)
Inferior STEMI (II, III, aVF) is caused by RCA occlusion in approximately 80% of cases. Always obtain right-sided leads (V3R, V4R) to exclude RV infarction — avoid nitrates if RV infarct is present.
Q4. You calculate a QTc of 520 ms in a male patient receiving azithromycin and haloperidol. What is your immediate nursing action?
  • Continue current medications and recheck QTc in 24 hours
  • Administer IV magnesium prophylactically and notify physician immediately
  • Reduce the haloperidol dose by 50%
  • Administer lidocaine 1 mg/kg IV as prophylaxis
Answer: B — IV magnesium and notify physician
QTc > 500 ms represents high risk for Torsades de Pointes. Immediate notification of the physician is essential. IV magnesium (2g slow IV) should be administered. Both QT-prolonging drugs should be reviewed for discontinuation.
Q5. A patient in the ED presents with WPW syndrome and rapid AF at 220 bpm. Which medication is CONTRAINDICATED?
  • Procainamide
  • DC cardioversion
  • Adenosine
  • Flecainide
Answer: C — Adenosine
AV nodal blockers (adenosine, digoxin, diltiazem, verapamil, beta-blockers) are contraindicated in WPW + AF because blocking the AV node channels all conduction through the accessory pathway, potentially causing VF. Use procainamide or DC cardioversion.
Q6. Which ECG finding is pathognomonic of complete (third-degree) heart block?
  • Progressive PR prolongation with dropped QRS
  • Fixed PR interval with intermittently dropped QRS
  • Regular P waves and regular QRS complexes at different rates with no relationship
  • Absent P waves with slow irregular ventricular rhythm
Answer: C — Independent regular P and QRS
Complete heart block shows complete AV dissociation: P waves march independently at the sinus rate, QRS complexes march at the escape rhythm rate, and the two are completely unrelated. This is the hallmark of 3rd degree block.
Q7. A pain-free patient has deeply symmetric inverted T waves in V2 and V3 with a minimally elevated troponin. What does this ECG pattern suggest?
  • Benign early repolarisation
  • Pulmonary embolism (PE)
  • Wellens' syndrome (critical LAD stenosis)
  • Right ventricular hypertrophy
Answer: C — Wellens' syndrome
Wellens' syndrome Type B shows deeply symmetric inverted T waves V2–V3 in a patient who is now pain-free. This indicates critical proximal LAD stenosis. Do NOT discharge, do NOT exercise test. Requires urgent cath lab referral.
Q8. The LBBB mnemonic "WiLLiaM" describes which ECG pattern?
  • W in V5/V6 and M in V1
  • W in V1 and M in V5/V6
  • M in both V1 and V5/V6
  • W in V1 and V5/V6
Answer: B — W in V1 and M in V5/V6
LBBB: WiLLiaM = W in V1, M in V5/V6. RBBB: MaRRoW = M (RSR') in V1, W (broad S) in V5/V6. Remember: WiLLiaM is LBBB, MaRRoW is RBBB.
Q9. A patient has a dominant R wave in V1 and ST depression in V1–V3. What territory of myocardial infarction should be suspected?
  • Anterior STEMI
  • Lateral STEMI
  • Posterior STEMI
  • Right ventricular infarction
Answer: C — Posterior STEMI
In posterior STEMI, reciprocal changes appear in V1–V3: tall R wave (= reciprocal of posterior Q wave), ST depression (= reciprocal of posterior ST elevation), and upright T waves. Confirm with posterior leads V7–V9. Caused by LCx or RCA occlusion.
Q10. You are preparing a female patient for a 12-lead ECG. She is obese with large breasts. Regarding V4-V6 placement, which statement is correct?
  • Place electrodes on the breast tissue to maintain anatomical position
  • Skip V4-V6 if access is difficult and use posterior leads instead
  • Place electrodes under the breast tissue at the anatomically correct rib-space positions
  • Use male-lead positioning as gender does not affect placement
Answer: C — Place under the breast
In female patients, electrodes should be placed under the breast tissue at the correct anatomical positions (5th ICS mid-clavicular for V4, etc.). Placing on top of breast tissue causes ST and T-wave abnormalities that may be falsely interpreted as ischaemia.
ECG Rate & QT Calculator
Enter ECG measurements to calculate heart rate, QT duration, QTc (Bazett), and Torsades de Pointes risk assessment.
Heart Rate from R-R (300 ÷ large sq.)
QT Duration
RR Duration
QTc (Bazett: QT ÷ √RR)
QTc Interpretation
Normal Threshold
Drug Review Trigger

This guide is intended for qualified nursing professionals and exam preparation. Always follow your institution's protocols and consult a cardiologist for individual patient management decisions.

GCC Nursing Clinical Reference Series • Advanced ECG Interpretation & Arrhythmia Nursing